This inventor holds 3 USPTO granted patents. Top assignee: Merrell Dow Pharmaceuticals. Active years: 1989-1991.
Company Filing History:
Years Active: 1989-1991
Title: The Innovations of Phillip J Robinson
Introduction
Phillip J Robinson is a notable inventor based in Fitzroy, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as protein kinase C inhibitors. With a total of three patents to his name, Robinson's work has implications for the treatment of various medical conditions, including hypertension and asthma.
Latest Patents
Robinson's latest patents include a process for preparing quinoline aldehyde and ketone derivatives. This invention relates to novel quinolyloxazole-2-ones, which are useful as protein kinase C inhibitors. The compounds developed through this process are effective in treating hypertension and asthma. Additionally, the invention includes a novel procedure for producing an intermediate ketone compound. This involves the reaction of a bromo-quinoline compound with butyl lithium, followed by further reactions with N-methyl-N-methoxyalkanamide.
Career Highlights
Phillip J Robinson has established a successful career at Merrell Dow Pharmaceuticals. His innovative work has contributed to advancements in pharmaceutical research and development. Robinson's expertise in chemistry and pharmacology has positioned him as a key figure in his field.
Collaborations
Throughout his career, Robinson has collaborated with notable colleagues, including Winton D Jones and George P Claxton. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Phillip J Robinson's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the treatment of critical health conditions, showcasing the importance of innovation in medicine.